Week of June 16 - 22, 2019


Alpelisib (Piqray®)

Alpelisib (Piqray®) is a kinase inhibitor used in combination with fulvestrant in the treatment of metastatic or advanced breast cancer with a PIK3CA(phosphatidylinositol 3-kinase) mutation.

Erdafitinib (Balversa™)

Erdafitinib is a tyrosine kinase inhibitor, a targeted therapy indicated for the treatment of some locally advanced or metastatic urothelial cancers.

Trastuzumab-dttb (Ontruzant®)

Trastuzumab-dttb (Ontruzant®) is a biosimilar monoclonal antibody used in the treatment of some types of breast and gastric cancer.

Proton Therapy for Gynecologic Tumors

In this webinar, Dr. Neil Taunk, MD, MS, Assistant Professor and Chief of Gynecologic Radiation Oncology at Penn Medicine, provides an overview of proton radiation therapy for gynecologic cancers.

Blood Products and Transfusions

This section contains articles that explain the different types of blood products, and how and why they are transfused. 

Blogs

The Conception of OncoLink – A Perspective
by Carolyn Vachani, MSN, RN, AOCN
March 1, 2012

“No Shave November”
by Angelo Melendez
November 10, 2016
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
R
S
T
U
V
X
Y
Z
#
 
A
B
C
E
F
G
H
K
L
M
N
O
P
R
S
T
U
V
 
 
Stay informed with the latest information from OncoLink!   Subscribe to OncoLink eNews
View our newsletter archives